Latest filing published 22 Jan 2024 for Y-mAbs Therapeutics, Inc..
Insider track record
No signal scores available.
Steen Lisby: trading record in brief
This profile gathers the share dealings of Steen Lisby in Y-mAbs Therapeutics, Inc. The record holds 2 filings, for trades running from 17 January 2023 to 18 January 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 22 January 2024, reports a share grant in Y-mAbs Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Steen Lisby
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,800 shares0Common StockSEC:0001415889-24-001648:0
- 17,800 shares0Common stockSEC:0001104659-23-005030:0
2 of 2 declarations